ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma

Lin, Xian; Luo, Lianxiang; Zou, Yujiao; Chen, Jian*广东医学院; 北京大学; 南方医科大学
Frontiers in Genetics2022-9-2DOI: 10.3389/fgene.2022.991936
4被引7阅读
引用收藏
分享

摘要

Purpose: Hepatocellular carcinoma (HCC) is a severe malignant tumor with high incidence and mortality. LncRNAs present broad clinical application prospects. Herein, we aim to identify a cancer stemness associated lncRNA and reveal its role in HCC diagnosis, prognosis evaluation, and progression. Methods: The cancer stemness-associated LINC02475 in HCC samples were identified using bioinformatics analysis. Cellular and molecular experiments were conducted to elucidate the role of LINC02475 in HCC. Results: The firm links between LINC02475 and HCC stemness and prognosis were demonstrated by bioinformatics analysis of public cancer datasets. LINC02475 expression was elevated in HCC, performed well in the diagnosis, and independently predicts poor overall survival (hazard ratio = 1.389, 95% confidence interval = 1.047-1.843, p = 0.023), as well as progression-free survival (hazard ratio = 1.396, 95% confidence interval = 1.016-1.917, p = 0.040) of HCC patients. Moreover, LINC02475 enhanced the tumorigenic pathways necessary for cell stemness, DNA replication required for cell proliferation, epithelial-mesenchymal transition involved in metastasis, and DNA damage repair pathways that drove cell radioresistance and cisplatin resistance, thus promoting HCC progression. Conclusion: Cancer stemness-associated LINC02475 independently predicted a poor prognosis and promoted HCC progression by enhancing stemness, proliferation, metastasis, radioresistance, and chemoresistance. Our study lays a foundation for the clinical application of LINC02475 as a novel biomarker and target for the diagnosis, prognosis evaluation, as well as treatment of HCC.

学科与关键词

关键词
hepatocellular carcinomaprognosiscancer stemnessLINC02475lncRNAs
相关
加载中…
  • LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
    Luo, Yue; Lin, Junhao; Zhang, Jiakang; Song, Zhenghui; Zheng, Dayong; Chen, Fengsheng; Zhuang, Xuefen; Li, Aimin*; Liu, Xinhui*Canadian Journal of Gastroenterology and Hepatology, 2021, 2021: 9990338.被引 9
  • Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma
    Lin, Xian; Chen, Jian; Li, Xin; Chen, Dong; Luo, Kaixuan; Deng, Yongxing; Yang, Dinghua*; Huang, Zunnan*; Tao, Cheng*Archives of Toxicology, 2023, 97(6): 1627-1647.被引 2
  • Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
    Mai, Haoming; Xie, Haisheng; Luo, Mengqi; Hou, Jia; Chen, Jiaxuan; Hou, Jinlin*; Jiang, De-ke*Cancers, 2022, 14(3): 563.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-09-02
卷期
第 13 卷
页码
991936
DOI
10.3389/fgene.2022.991936
期刊等级
3区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation; Guangdong Basic and Applied Basic Research Foundation [2021T140468]; Scientific Research Foundation of Peking University Shenzhen Hospital [2021A1515111089]; National Natural Science Foundation of China [KYQD202100X, KYQD2021054]; [81903116]

作者

  • L

    Lin, Xian (第一作者)

    hong kong univ sci & technol · peking univ

  • L

    Luo, Lianxiang

    guangdong med univ

查看全部 4 位作者收起作者
  • Z

    Zou, Yujiao

    southern med univ

  • C

    Chen, Jian (通讯)

    hong kong univ sci & technol · peking univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417